N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142931 |
| CAS No | NA |
| Mol.F. | C19H24N4O7S |
| Mol.Wt. | 452.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142932 |
| CAS No | NA |
| Mol.F. | C24H27N5O6S |
| Mol.Wt. | 513.57 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142933 |
| CAS No | NA |
| Mol.F. | C16H24N4O4S |
| Mol.Wt. | 368.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142934 |
| CAS No | NA |
| Mol.F. | C19H24N4O7S |
| Mol.Wt. | 452.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142935 |
| CAS No | NA |
| Mol.F. | C16H19N3O3 |
| Mol.Wt. | 301.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142936 |
| CAS No | NA |
| Mol.F. | C16H20N4O5S |
| Mol.Wt. | 380.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142937 |
| CAS No | NA |
| Mol.F. | C24H31N5O8S |
| Mol.Wt. | 549.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142938 |
| CAS No | NA |
| Mol.F. | C24H33N5O7S |
| Mol.Wt. | 535.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142939 |
| CAS No | NA |
| Mol.F. | C15H27N3O2 |
| Mol.Wt. | 281.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142940 |
| CAS No | NA |
| Mol.F. | C20H26N4O8S |
| Mol.Wt. | 482.51 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142941 |
| CAS No | NA |
| Mol.F. | C16H18ClN3O5S |
| Mol.Wt. | 399.85 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142942 |
| CAS No | NA |
| Mol.F. | C16H19N3O6S |
| Mol.Wt. | 381.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142943 |
| CAS No | NA |
| Mol.F. | C21H28N4O7S |
| Mol.Wt. | 480.54g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142944 |
| CAS No | NA |
| Mol.F. | C26H37N5O6S |
| Mol.Wt. | 547.67g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142945 |
| CAS No | NA |
| Mol.F. | C18H20N4O8S |
| Mol.Wt. | 452.44 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142946 |
| CAS No | NA |
| Mol.F. | C18H18N4O10S |
| Mol.Wt. | 482.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |